{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T04:14:26Z","timestamp":1789532066724,"version":"build-2803163510"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.clnesp.2023.07.013","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T02:13:30Z","timestamp":1689214410000},"page":"305-310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes mellitus and moderate to severe hepatic fibrosis: A retrospective study"],"prefix":"10.1016","volume":"57","author":[{"given":"Kanika","family":"Tyagi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Madan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surya","family":"Prakash Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irshad Ahmad","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koel","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5785-5833","authenticated-orcid":false,"given":"Anoop","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.clnesp.2023.07.013_bib1","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.jdiacomp.2018.08.001","article-title":"Body fat, metabolic syndrome and hyperglycemia in South Asians","volume":"32","author":"Misra","year":"2018","journal-title":"J\u00a0Diabet Complicat"},{"issue":"3","key":"10.1016\/j.clnesp.2023.07.013_bib2","first-page":"285","article-title":"A\u00a0case-control study on insulin resistance, metabolic co-variates & prediction score in non-alcoholic fatty liver disease","volume":"129","author":"Bajaj","year":"2009","journal-title":"Indian J Med Res"},{"issue":"5","key":"10.1016\/j.clnesp.2023.07.013_bib3","first-page":"729","article-title":"Diabetes risk prediction model for non-obese Asian Indians residing in North India using cut-off values for pancreatic and intra-abdominal fat volume and liver span","volume":"8","author":"Anoop","year":"2016","journal-title":"J\u00a0Diabetes"},{"issue":"3","key":"10.1016\/j.clnesp.2023.07.013_bib4","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1089\/met.2021.0104","article-title":"Clinicopathological profile and outcome of a large cohort of patients with nonalcoholic fatty liver disease from South asia: interim results of the Indian consortium on nonalcoholic fatty liver disease","volume":"20","author":"Duseja","year":"2022","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.clnesp.2023.07.013_bib5","first-page":"519","article-title":"High prevalence of hepatic steatosis and hepatic fibrosis in patients with type 2 diabetes mellitus","volume":"46","author":"Gupta","year":"2021","journal-title":"Clin Nutr"},{"issue":"6","key":"10.1016\/j.clnesp.2023.07.013_bib6","doi-asserted-by":"crossref","first-page":"e2267","DOI":"10.1210\/clinem\/dgac138","article-title":"Dapagliflozin improves body fat patterning, and hepatic and pancreatic fat in patients with type 2 diabetes in north India","volume":"107","author":"Ghosh","year":"2022","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clnesp.2023.07.013_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.609135","article-title":"Sodium-glucose Co-transporter 2 inhibitors for non-alcoholic fatty liver disease in asian patients with type 2 diabetes: a meta-analysis","volume":"11","author":"Wong","year":"2021","journal-title":"Front Endocrinol"},{"issue":"3","key":"10.1016\/j.clnesp.2023.07.013_bib8","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/jhep.2000.16602","article-title":"Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF)","volume":"32","author":"Cadranel","year":"2000","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.clnesp.2023.07.013_bib9","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1053\/jhep.2003.50223","article-title":"Diagnosing fibrosis in hepatitis C: is the pendulum swinging from biopsy to blood tests?","volume":"37","author":"Afdhal","year":"2003","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.clnesp.2023.07.013_bib10","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.ultrasmedbio.2003.07.001","article-title":"Transient elastography: a new noninvasive method for assessment of hepatic fibrosis","volume":"29","author":"Sandrin","year":"2003","journal-title":"Ultrasound Med Biol"},{"issue":"11","key":"10.1016\/j.clnesp.2023.07.013_bib11","first-page":"604","article-title":"Performance of transient elastography (TE) and factors associated with discordance in non-alcoholic fatty liver disease","volume":"14","author":"Mahadeva","year":"2013","journal-title":"J\u00a0Dig Dis"},{"issue":"4","key":"10.1016\/j.clnesp.2023.07.013_bib12","first-page":"242","article-title":"Assessment of transient elastography (FibroScan) for diagnosis of fibrosis in non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"7","author":"Hashemi","year":"2016","journal-title":"Caspian J Intern Med"},{"issue":"4","key":"10.1016\/j.clnesp.2023.07.013_bib13","doi-asserted-by":"crossref","first-page":"339","DOI":"10.5114\/ceh.2020.102173","article-title":"SGLT2 inhibitors for improving hepatic fibrosis and steatosis in non-alcoholic fatty liver disease complicated with type 2 diabetes mellitus: a systematic review","volume":"6","author":"Dwinata","year":"2020","journal-title":"Clin Exp Hepatol"},{"issue":"4","key":"10.1016\/j.clnesp.2023.07.013_bib14","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.dld.2021.08.017","article-title":"The safety and efficacy evaluation of sodium-glucose co-transporter 2 inhibitors for patients with non-alcoholic fatty liver disease: an updated meta-analysis","volume":"54","author":"Mo","year":"2022","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.clnesp.2023.07.013_bib15","article-title":"Effects of SGLT2 inhibitors on hepatic fibrosis and steatosis: a systematic review and meta-analysis","volume":"14","author":"Zhou","year":"2023","journal-title":"Front Endocrinol"},{"issue":"16","key":"10.1016\/j.clnesp.2023.07.013_bib16","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.2169\/internalmedicine.4398-19","article-title":"SGLT2 inhibitor treatment outcome in nonalcoholic fatty liver disease complicated with diabetes mellitus: the long-term effects on clinical features and liver histopathology","volume":"59","author":"Akuta","year":"2020","journal-title":"Intern Med"},{"issue":"9","key":"10.1016\/j.clnesp.2023.07.013_bib17","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1002\/hep4.2005","article-title":"Favorable impact of long-term SGLT2 inhibitor for NAFLD complicated by diabetes mellitus: a 5-year follow-up study","volume":"6","author":"Akuta","year":"2022","journal-title":"Hepatol Commun"},{"issue":"6","key":"10.1016\/j.clnesp.2023.07.013_bib18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/cld.714","article-title":"SGLT2 inhibitors and cirrhosis: a unique perspective on the comanagement of diabetes mellitus and ascites","volume":"11","author":"Saffo","year":"2018","journal-title":"Clin Liver Dis"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457723005466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457723005466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:16:52Z","timestamp":1762499812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457723005466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":18,"alternative-id":["S2405457723005466"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2023.07.013","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes mellitus and moderate to severe hepatic fibrosis: A retrospective study","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2023.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}